İ. Kızıldağ Yırgın Et Al. , "Immune checkpoint inhibitors Assessment of the performance and the agreement of iRECIST, irRC, and irRECIST," Journal of Cancer Research and Therapeutics , no.2, pp.1-7, 2023
Kızıldağ Yırgın, İ. Et Al. 2023. Immune checkpoint inhibitors Assessment of the performance and the agreement of iRECIST, irRC, and irRECIST. Journal of Cancer Research and Therapeutics , no.2 , 1-7.
Kızıldağ Yırgın, İ., Dogan, İ., Engin, G., Vatansever, S., & Erturk, S. M., (2023). Immune checkpoint inhibitors Assessment of the performance and the agreement of iRECIST, irRC, and irRECIST. Journal of Cancer Research and Therapeutics , no.2, 1-7.
Kızıldağ Yırgın, İnci Et Al. "Immune checkpoint inhibitors Assessment of the performance and the agreement of iRECIST, irRC, and irRECIST," Journal of Cancer Research and Therapeutics , no.2, 1-7, 2023
Kızıldağ Yırgın, İnci K. Et Al. "Immune checkpoint inhibitors Assessment of the performance and the agreement of iRECIST, irRC, and irRECIST." Journal of Cancer Research and Therapeutics , no.2, pp.1-7, 2023
Kızıldağ Yırgın, İ. Et Al. (2023) . "Immune checkpoint inhibitors Assessment of the performance and the agreement of iRECIST, irRC, and irRECIST." Journal of Cancer Research and Therapeutics , no.2, pp.1-7.
@article{article, author={İnci KIZILDAĞ YIRGIN Et Al. }, title={Immune checkpoint inhibitors Assessment of the performance and the agreement of iRECIST, irRC, and irRECIST}, journal={ Journal of Cancer Research and Therapeutics}, year=2023, pages={1-7} }